Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation
- 1 September 1992
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 20 (3) , 527-532
- https://doi.org/10.1016/0735-1097(92)90003-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or PlaceboNew England Journal of Medicine, 1991
- Design of a multicenter randomized trial for the Stroke Prevention in Atrial Fibrillation Study. The Stroke Prevention in Atrial Fibrillation Investigators.Stroke, 1990
- The Cardiac Arrhythmia Suppression Trial (CAST)New England Journal of Medicine, 1989
- Clinical Characteristics of Patients with Ventricular Fibrillation during Antiarrhythmic Drug TherapyNew England Journal of Medicine, 1988
- Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient careAmerican Heart Journal, 1986
- Antiarrhythmic Drugs: a Possible Cause of Out-of-Hospital Cardiac ArrestNew England Journal of Medicine, 1983
- Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.Circulation, 1982
- Procainamide-lnduced polymorphous ventricular tachycardiaThe American Journal of Cardiology, 1981
- Quinidine SyncopeCirculation, 1964
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958